SE9803609D0 - New peptides and cDNA as well as use thereof - Google Patents
New peptides and cDNA as well as use thereofInfo
- Publication number
- SE9803609D0 SE9803609D0 SE9803609A SE9803609A SE9803609D0 SE 9803609 D0 SE9803609 D0 SE 9803609D0 SE 9803609 A SE9803609 A SE 9803609A SE 9803609 A SE9803609 A SE 9803609A SE 9803609 D0 SE9803609 D0 SE 9803609D0
- Authority
- SE
- Sweden
- Prior art keywords
- well
- peptides
- cdna
- new peptides
- hyperlipidemia
- Prior art date
Links
Abstract
The invention relates to new peptides corresponding substantially to the intracellular C-terminal domain of a mammalian HDL-receptor, or mimetics or functionally equivalent homologues, analogues or fragments thereof, and also to cDNA encoding such peptides. Said peptides are suitable for use in medicinal products for treatment of hyperlipidemia by modulation of cholesterol, bile acid, and/or lipid metabolism of a patient, as well as for identification of drug targets for treatment of hyperlipidemia.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803609A SE9803609D0 (en) | 1998-10-22 | 1998-10-22 | New peptides and cDNA as well as use thereof |
PCT/SE1999/001902 WO2000023475A1 (en) | 1998-10-22 | 1999-10-22 | Intracellular c-terminal hdl-receptor domain |
AU14291/00A AU1429100A (en) | 1998-10-22 | 1999-10-22 | Intracellular c-terminal hdl-receptor domain |
EP99970667A EP1131353A1 (en) | 1998-10-22 | 1999-10-22 | Intracellular c-terminal hdl-receptor domain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803609A SE9803609D0 (en) | 1998-10-22 | 1998-10-22 | New peptides and cDNA as well as use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9803609D0 true SE9803609D0 (en) | 1998-10-22 |
Family
ID=20413040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9803609A SE9803609D0 (en) | 1998-10-22 | 1998-10-22 | New peptides and cDNA as well as use thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1131353A1 (en) |
AU (1) | AU1429100A (en) |
SE (1) | SE9803609D0 (en) |
WO (1) | WO2000023475A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6429289B1 (en) * | 1994-06-23 | 2002-08-06 | Massachusetts Institute Of Technology | Class BI and CI scavenger receptors |
US5925333A (en) * | 1995-11-15 | 1999-07-20 | Massachusetts Institute Of Technology | Methods for modulation of lipid uptake |
-
1998
- 1998-10-22 SE SE9803609A patent/SE9803609D0/en unknown
-
1999
- 1999-10-22 AU AU14291/00A patent/AU1429100A/en not_active Abandoned
- 1999-10-22 WO PCT/SE1999/001902 patent/WO2000023475A1/en not_active Application Discontinuation
- 1999-10-22 EP EP99970667A patent/EP1131353A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU1429100A (en) | 2000-05-08 |
WO2000023475A1 (en) | 2000-04-27 |
EP1131353A1 (en) | 2001-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE467425T1 (en) | TARGETED DELIVERY OF PHARMACEUTICAL AGENTS TO INJURED TISSUES | |
HK1043543A1 (en) | Modified factor VIII. | |
BG103793A (en) | COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS | |
ATE374625T1 (en) | DENDRIMERS FOR USE IN TARGETED ADMINISTRATION | |
AR024074A1 (en) | ABETA FRAGMENT JOINED WITH A BEARING PEPTIDE TO PREVENT OR TREAT DISEASES ASSOCIATED WITH ABETA AMILOID DEPOSITS, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND ITS USE IN THE PREPARATION OF MEDICINES. | |
BR9710452A (en) | Anïïlogos of exendin processes for its preparation and medicines containing the same | |
BG104075A (en) | Combined treatment including atorvastatin and an antihypertonic form | |
GB2340121B (en) | Delivery system | |
DE60225118D1 (en) | COMBINED USE OF FACTOR VII POLYPEPTIDES AND FACTOR VIII POLYPEPTIDES | |
IL151371A (en) | Modified porcine factor viii and pharmaceutical compositions containing the same | |
NZ263344A (en) | Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use | |
BRPI0409914A (en) | substituted carboxylic acids | |
PT749317E (en) | THERAPEUTIC APPLICATIONS OF DIMERIC PRODUCTS OF PERMEABILITY INDUCED BACTERICID PROTEINS | |
BR9810121A (en) | Use of native or esterified petroselinic acid | |
SE0002202D0 (en) | New peptides | |
ATE297750T1 (en) | USE OF HSP70 PROTEIN | |
BR0111506A (en) | Macromolecular drug complexes and compositions containing same | |
EP1071443A4 (en) | Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof | |
DE59906362D1 (en) | USE OF LIPOPEPTIDES OR LIPOPROTEINS FOR WIND TREATMENT | |
HUP0001458A2 (en) | Specific pancreatic lipase inhibitor peptides, pharmaceutical compositions and diagnostical reagents comprising thereof and their applications | |
SE9803609D0 (en) | New peptides and cDNA as well as use thereof | |
WO2001007479A3 (en) | Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases | |
DK1165102T3 (en) | Matrix protein preparations for grafting in non-mineralized tissue | |
IT1294967B1 (en) | IMMUNOGENIC COMPOSITION FROM TLP | |
ATE278014T1 (en) | TARGET FOR THE TREATMENT OF ATHEROSCLEROSIS, OBESITY AND DIABETIS TYPE II |